Industry luminaries Betsy Holden and Karen Katen to help guide the firm to its next level of growth
Dec. 11, 2012
/PRNewswire/ - Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) and technology services, today announced that it appointed
to Catamaran's Board of Directors, effective
December 10, 2012
. Ms. Holden and Ms. Katen will round out the firm's board which includes a diverse array of seasoned business leaders representing leading healthcare, IT, private equity, and consumer product companies.
"The appointment of
- two of the most esteemed women in business today - to Catamaran's board will further enhance our successful shepherding of shareholder interests and our ability to deliver value to clients," said
, Chairman and CEO of Catamaran. "Together, Betsy, with a proven track record of value creation as former CEO of one of the world's most recognized brands, and Karen, a well-respected executive with an impressive healthcare pedigree, bolster Catamaran's commitment to driving smart growth."
Ms. Holden, a Senior Advisor to McKinsey & Company, works with clients across industries on strategy, marketing, innovation and board effectiveness initiatives. Prior to her current position, she was co-CEO of Kraft Foods and CEO of Kraft Foods North America, where she built a strong record of success in brand building, organic growth and cost management for
largest food company at the time.
Ms. Katen is a Senior Advisor to Essex Woodlands, a healthcare investment firm, where she focuses on building best-of-breed companies. Prior to this, Ms. Katen served as Vice Chairman of Pfizer, responsible for providing a broad array of innovative human-health services. With more than 30 years of experience in the healthcare industry, including guiding Pfizer's industry-leading portfolio, Ms. Katen was recognized among
magazine's "50 Most Powerful Women in Business" for eight consecutive years.
Catamaran, the industry's fastest-growing pharmacy benefit manager, helps organizations and the communities they serve take control of prescription drug costs. Managing more than 250 million prescriptions each year on behalf of 25 million members, our flexible, holistic solutions improve patient care and empower individuals to take charge of their health. Processing one in every five prescription claims in the U.S., Catamaran's skill and scale deliver compelling financial results and sustainable improvement in the overall health of members. Catamaran is headquartered in
with multiple locations in the U.S. and
. For more information, please visit